Roll Back Malaria Progress & Impact Series
Benchmarking Progress, Disseminating Findings, Catalyzing Action
In March 2010 the Roll Back Malaria (RBM) Partnership launched the RBM Progress & Impact Series, a strategic effort to secure high levels of commitment to malaria control among donor countries, international health organizations and governments of endemic and epidemic countries. By benchmarking progress this effort has sought to ensure a level of support that would result in sustained, longterm commitment and success toward ultimately ridding the world of malaria.
Today's environment of increased accountability and accelerated national action requires credible evidence of progress toward mitigating the disease, along with efforts to make findings available to all constituencies. Ensuring transparency of performance against targets also highlights barriers to implementation and informs advocacy required to eliminate the barriers. Achieving this has been the aim of the series, which is being developed through 2011.
Demonstrating progress, informing action
By aggregating, analyzing and sharing data from a variety of sources, the series shows progress, documents impact and drives future investment and action. It also informs vigorous advocacy for sustained or increased malaria control resources and prioritization at the global and national levels.
The malaria control landscape in sub-Saharan Africa has changed dramatically over the past five years. Since 2004, malaria funding from the Global Fund to Fight AIDS, Tuberculosis and Malaria has increased almost threefold, and new funding mechanisms such as the World Bank's Booster Program and the U.S. President's Malaria Initiative have provided much-needed implementation support and funding for commodities in 17 of 47 sub-Saharan African countries. The path to universal coverage is becoming clearer.
New targets and opportunities
The global malaria community is embracing ambitious new targets to put an end to malaria. The Global Malaria Action Plan (GMAP), developed by the RBM Partnership in 2008, is guiding investments through a continuum from scaling up for impact, to sustained impact, to elimination, ultimately aiming to eradicate malaria. The GMAP targets for 2015 and beyond include the reduction of global malaria deaths to near zero, the reduction of global malaria cases by 75% and, in at least eight to ten new countries since 2008 (including the entire WHO European Region), the elimination of malaria.